TMCnet News
MAXIMUS Reports Second Quarter Results for Fiscal Year 2016MAXIMUS (NYSE: MMS), a leading provider of government services worldwide, today reported financial results for the three and six months ended March 31, 2016. Highlights for the second quarter of fiscal year 2016 include:
For the second quarter of fiscal 2016, revenue increased 26% to $606.5 million compared to $481.8 million reported for the same period last year. The increase in revenue was attributable to acquisitions that accounted for growth of 15% and organic growth of 13%, principally from the Health Services Segment. The increase in revenue was partially offset by a 2% decline from unfavorable foreign currency translation. For the second quarter of fiscal 2016, net income attributable to MAXIMUS totaled $48.8 million, or $0.74 of diluted earnings per share. This compares to diluted earnings per share of $0.58 for the second quarter of fiscal 2015. The second quarter of fiscal 2016 received the benefit of out-of-period revenue and income of approximately $6.6 million, or approximately $0.08 of diluted earnings per share, resulting from contract modifications on the HAAS contract in the U.K. Total Company operating margin for the second quarter of fiscal 2016 was 12.8%. "Our financial results for the quarter demonstrate that overall, we have made solid progress on start-up projects, particularly the HAAS contract. Our current trends confirm that we are on track to hit full productivity on this contract by the end of the summer and we have an increased level of confidence that we are on a path to achieve our long-term operational and financial goals over the life of the contract," commented MAXIMUS CEO Richard A. Montoni. Health Services Segment Health Services Segment revenue for the second quarter of fiscal 2016 increased 22% to $330.6 million compared to $270.9 million reported for the same period last year. The year-over-year increase in revenue was nearly all organic and principally driven by the U.K. HAAS contract and, to a lesser extent, new work and expansion on existing contracts in the U.S. health business. The Ascend acquisition, which occurred in the quarter, accounted for less than 1% of Segment growth in the quarter. Health Segment growth was offset by a 2% decline from unfavorable foreign currency translation. Operating margin for the second quarter of fiscal 2016 increased to 17.2% compared to 15.3% reported in the prior-year period. Operating margin in the second quarter benefitted from out-of-period revenue and income related to: 1) a previously disclosed contract change order that was recognized in the second quarter, and 2) modifications on the HAAS contract. Excluding the benefit of out-of-period revenue and income related to contract modifications in the second quarter of 2016, operating margin would have been 13.2% in the quarter. U.S. Federal Services Segment U.S. Federal Services Segment revenue for the second quarter of fiscal 2016 increased 51% to $150.2 million compared to $99.5 million reported for the same period last year. All growth in the quarter was acquired and partially offset by expected reductions from the closure of one of the Company's customer contact centers tied to the Federal Marketplace. Operating margin for the second quarter was 10.0% compared to 9.7% reported for the prior-year period. Human Services Segment Human Services Segment revenue for the second quarter of fiscal 2016 increased 13% to $125.7 million compared to $111.4 million for the same period last year. Year-over-year revenue growth was principally driven by acquisitions. The Segment was unfavorably impacted by a 5% decline in foreign currency translation. Operating margin for the second quarter was 7.8% compared to 12.5% for the same period last year. The anticipated reduction in margin was principally due to the ongoing ramp up of the new jobactive contract in Australia. The Company now expects that the jobactive contract will operate at the lower end of its target operating margin range of 10-15% in the second half of fiscal 2016 as a result of lower-than-expected volumes in the near term. Sales and Pipeline Year-to-date signed contract awards at March 31, 2016 totaled $1.1 billion. New contracts pending (awarded but unsigned) totaled $143.2 million. The sales pipeline at March 31, 2016 increased to $3.2 billion (comprised of approximately $543 million in proposals pending, $261 million in proposals in preparation, and $2.4 billion in opportunities tracking). The pipeline includes opportunities across all Segments and geographies. This compares to a pipeline of $2.6 billion for the same period last year. Of the $3.2 billion in pipeline at March 31, 2016, more than half is associated with new work. The Company's reported pipeline only reflects those opportunities where MAXIMUS expects that the request for proposal will be released within the next six months. Balance Sheet and Cash Flows Cash and cash equivalents at March 31, 2016 totaled $60.8 million. For the three-months ended March 31, 2016, cash provided by operating activities totaled $20.5 million, with free cash flow of $11.3 million. At March 31, 2016, Days Sales Outstanding (DSOs) were within the Company's expected range at 70 days, and lower sequentially by five days compared to DSOs of 75 days in the first quarter. On February 29, 2016, MAXIMUS paid a quarterly cash dividend of $0.045 per share. On April 19, 2016, the Company announced a $0.045 per share cash dividend, payable on May 31, 2016 to shareholders of record on May 13, 2016. During the second quarter of fiscal 2016, MAXIMUS did not repurchase any common stock. At March 31, 2016, MAXIMUS had $139.4 million available for repurchases under its Board-authorized share repurchase program. Outlook The Company still expects revenue to range between $2.4 billion and $2.5 billion for fiscal 2016. MAXIMUS is narrowing its earnings guidance and now expects GAAP diluted earnings per share to range between $2.50 and $2.70 for fiscal 2016. This compares to the Company's prior range of $2.40 to $2.70 of GAAP diluted earnings per share. Fiscal year 2016 earnings guidance assumes that certain contracts in start-up will continue to mature and provide increasing contributions in the second half of the year, coupled with the addition of new work. The Company's guidance does not include any future acquisitions or significant legal expenses or recoveries. Website Presentation, Conference Call and Webcast Information MAXIMUS will host a conference call this morning, May 5, 2016, at 9:00 a.m. (ET). The call is open to the public and can be accessed under the Investor Relations page of the Company's website at http://investor.maximus.com or by calling: 877.407.8289 (Domestic)/+1.201.689.8341 (International) For those unable to listen to the live call, a replay will be available through May 19, 2016. Callers can access the replay by calling:
877.660.6853 (Domestic)/+1.201.612.7415 (International) About MAXIMUS Since 1975, MAXIMUS has operated under its founding mission of Helping Government Serve the People®, enabling citizens around the globe to successfully engage with their governments at all levels and across a variety of health and human services programs. MAXIMUS delivers innovative business process management and technology solutions that contribute to improved outcomes for citizens and higher levels of productivity, accuracy, accountability and efficiency of government-sponsored programs. With more than 16,000 employees worldwide, MAXIMUS is a proud partner to government agencies in the United States, Australia, Canada, New Zealand, Saudi Arabia and the United Kingdom. For more information, visit maximus.com. Non-GAAP Measures We utilize non-GAAP measures where we believe it will assist the user of our financial statements in understanding our business. The presentation of these measures is meant to complement, and not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to revenue growth, cash flows from operations or net income as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies. During the past twelve months, we have acquired Acentia, Ascend, Assessments Australia and Remploy. We believe users of our financial statements wish to evaluate the performance of our underlying business, excluding changes that have arisen due to businesses acquired. We provide organic revenue growth as a useful basis for assessing this. To calculate organic revenue growth, we compare current year revenue less revenue from these acquisitions to our prior year revenue. In the first six months of fiscal year 2016, 29% of our business has been generated outside the United States. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology which excludes the effect of year-over-year exchange rate fluctuations. We provide constant currency revenue movement as a useful basis for assessing this. To calculate constant currency revenue movement, we determine the current year's revenue for all foreign businesses using the exchange rates in the prior year. In order to sustain our cash flows from operations, we require regular refreshing of our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology which combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of the Company's operations and routine capital expenditure and excludes the cash flow effects of acquisitions, share repurchases, dividend payments and other financing transactions. We have provided a reconciliation of free cash flow to cash provided by operating activities. To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide days sales outstanding, or DSO. We calculate DSO by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days. Statements that are not historical facts, including statements about the Company's confidence and strategies and the Company's expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand or acceptance of the Company's products are forward-looking statements that involve risks and uncertainties. These uncertainties could cause the Company's actual results to differ materially from those indicated by such forward-looking statements and include reliance on government clients; risks associated with government contracting; risks involved in managing government projects; legislative changes and political developments; opposition from government unions; challenges resulting from growth; adverse publicity; and legal, economic, and other risks detailed in Exhibit 99.1 to the Company's most recent Annual Report filed with the Securities and Exchange Commission, found on maximus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160505005376/en/ |